Since 2017, we have focused on the development of new drugs along with the production and sale of the most common forms of oral solid dosage, including those in the form of pellets, granules, and the other specialised drug delivery systems. Our state-of-the-art production plants have new, patient-focused therapeutic products in a variety of treatment fields.